Syndax Pharmaceuticals Inc
SNDX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001395937
In the last 90 days, Syndax Pharmaceuticals Inc insiders filed 0 open-market purchases and 1 sale; 242 institutions reported holding it in 13F filings for Q2 2026, worth $2.36B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Syndax Pharmaceuticals Inc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 121
- −11 vs. Q1 2022
- Shares held
- 55.2M
- +764.6K (+1.4%) vs. Q1 2022
- Total value
- $1.06B
- +$116.1M (+12.3%) vs. Q1 2022
- New holders
- 13
- 48 more added
- Sold out
- 24
- 36 more reduced
4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SNDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 242 | $2.36B |
| Q1 2026 | 247 | $2.32B |
| Q4 2025 | 230 | $2.10B |
| Q3 2025 | 227 | $1.56B |
| Q2 2025 | 217 | $952.6M |
| Q1 2025 | 219 | $1.24B |
| Q4 2024 | 216 | $1.30B |
| Q3 2024 | 210 | $1.71B |
| Q2 2024 | 196 | $1.79B |
| Q1 2024 | 189 | $2.15B |
| Q4 2023 | 177 | $1.92B |
| Q3 2023 | 175 | $1.03B |
| Q2 2023 | 166 | $1.48B |
| Q1 2023 | 163 | $1.54B |
| Q4 2022 | 160 | $1.82B |
| Q3 2022 | 139 | $1.44B |
| Q2 2022 | 121 | $1.06B |
| Q1 2022 | 136 | $948.4M |
| Q4 2021 | 132 | $1.15B |
| Q3 2021 | 123 | $938.0M |
| Q2 2021 | 115 | $861.9M |
| Q1 2021 | 130 | $1.08B |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Syndax Pharmaceuticals Inc; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 907,856 | $17.5M | 0.00% | +52,441+6.1% | Added |
| HealthCor Management, L.P. | 923,400 | $17.8M | 1.83% | −257,100−21.8% | Reduced |
| Dimensional Fund Advisors LP | 961,106 | $18.5M | 0.01% | +76,772+8.7% | Added |
| Eversept Partners, LP | 994,362 | $19.1M | 1.87% | +994,362 | New |
| Aisling Capital Management LP | 1,025,000 | $19.7M | 14.07% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 1,111,111 | $21.4M | 0.45% | +1,111,111 | New |
| Sphera Funds Management Ltd. | 1,139,329 | $21.9M | 4.16% | −138,084−10.8% | Reduced |
| Adage Capital Partners GP, L.L.C. | 1,237,300 | $23.8M | 0.05% | +158,659+14.7% | Added |
| 683 Capital Management, LLC | 1,581,653 | $30.4M | 2.20% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,729,052 | $33.3M | 0.05% | −96,388−5.3% | Reduced |
| Avoro Capital Advisors LLC | 2,222,222 | $42.8M | 0.84% | +1,722+0.1% | Added |
| OrbiMed Advisors LLC | 2,323,300 | $44.7M | 0.87% | +165,000+7.6% | Added |
| BVF Inc | 2,356,934 | $45.3M | 2.19% | −37,780−1.6% | Reduced |
| State Street Corp | 2,435,517 | $46.9M | 0.00% | +55,180+2.3% | Added |
| Kynam Capital Management, LP | 2,512,240 | $48.3M | 12.47% | +579,440+30.0% | Added |
| Nantahala Capital Management, LLC | 2,663,087 | $51.2M | 4.44% | −29,216−1.1% | Reduced |
| Vanguard Group Inc | 2,780,903 | $53.5M | 0.00% | +348,465+14.3% | Added |
| Frazier Life Sciences Management, L.P. | 3,195,403 | $61.5M | 5.80% | 00.0% | Unchanged |
| Wellington Management Group LLP | 3,206,866 | $61.7M | 0.01% | +1,372,936+74.9% | Added |
| BlackRock Inc. | 3,795,909 | $73.0M | 0.00% | −2,241−0.1% | Reduced |
| Avidity Partners Management LP | 5,450,000 | $104.9M | 2.41% | +626,600+13.0% | Added |
| Eventide Asset Management, LLC | 0 | $0 | 0.00% | −1,165,000−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −484,900−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −360,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −182,100−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −115,094−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −57,804−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −43,145−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −42,073−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −41,800−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −40,804−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −27,664−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −25,913−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −22,844−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −16,925−100.0% | Sold out |
| Delphia (USA) Inc. | 0 | $0 | 0.00% | −11,740−100.0% | Sold out |
| Telemetry Investments, L.L.C. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −4,900−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −4,040−100.0% | Sold out |
| Prospera Financial Services Inc | 0 | $0 | 0.00% | −3,781−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −2,350−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −2,160−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −951−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −246−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Teachers Retirement System of the State of Kentucky | – | – | – | – | Not filed |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |